首页> 外文期刊>Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi >Role of oxytocin in prevention of postpartum hemorrhage in unplanned out‐of‐hospital deliveries treated by emergency medical services
【24h】

Role of oxytocin in prevention of postpartum hemorrhage in unplanned out‐of‐hospital deliveries treated by emergency medical services

机译:催产素在急救医疗服务治疗的无计划医院外递送中预防产后出血的作用

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Introduction Intramuscular or intravenous oxytocin is used in out‐of‐hospital emergency care in Finland to prevent postpartum hemorrhage after unplanned out‐of‐hospital deliveries. However, the use of oxytocin by emergency medical services is based on in‐hospital studies. The aim of this study was to determine whether the use of oxytocin is associated with diminished postpartum hemorrhage after unplanned out‐of‐hospital deliveries. Material and methods We studied patient records covering all unplanned out‐of‐hospital deliveries in the Helsinki University Hospital area between 1 January 2013 and 31 December 2017 inclusive. Oxytocin was available in ambulances responsible for half of the population of the study area and was not available in ambulances responsible for the other half. The study area corresponded to 25% of all deliveries in Finland. The primary outcome was the estimated total bleeding (mL). Secondary outcomes were (1) the first blood hemoglobin value measured in hospital (g/L), (2) whether blood hemoglobin was measured during the first 24?hours after delivery, (3) the need for red blood cell concentrate, (4) the need for uterotonic or prothrombotic medication in‐hospital during the first 24?hours, (5) the need for any postpartum operation during the first 24?hours and (6) composite outcome combining the secondary outcomes 2‐5. Results Of all ambulance responses in the study area, .04% concerned out‐of‐hospital deliveries. There were 216 analyzed out‐of‐hospital deliveries. Altogether, 111 of these occurred in the area with oxytocin available in ambulances and 105 in the area without. Oxytocin was administered in 57 of the 111 deliveries (51%) where it was available. No differences in the primary outcome ( P ?=?.548 for oxytocin available vs not available and P ?=?.381 for oxytocin used vs not used) or secondary outcomes were detected between those deliveries where oxytocin was available vs not available or between those where it was used vs not used. Conclusions Out‐of‐hospital oxytocin was not associated with diminished postpartum hemorrhage in this study setting. Oxytocin does not seem to be an essential drug for all ambulance units. The in‐hospital use of oxytocin was not evaluated and thus is not disputed by this study.
机译:摘要介绍肌肉内或静脉内催产素用于芬兰的医院外应力,以防止出生在医院外交付后的产后出血。然而,通过紧急医疗服务使用催产素基于住院内研究。本研究的目的是判断催产素的使用是否与外部医院外递送后的产后出血减少有关。我们研究了患者记录涵盖患者的患者记录,涵盖2013年1月1日至2017年12月31日至2017年12月31日之间的赫尔辛基大学住院地区的所有无计划医院送货。催产素可用于负责研究区域的一半人口的救护车,并且在对另一半负责的救护车中没有。研究区涉及芬兰所有交货的25%。主要结果是估计的总出血(ML)。二次结果是(1)在医院(G / L)测量的第一个血液血红蛋白值,(2)是否在递送后的前24个小时内测量血液血红蛋白,(3)需要红细胞浓缩物,(4 )在前24小时内,在医院中患有子宫或孕激酶药物,(5)在前24小时中的任何产后操作的需要,(6)组合二次结果2-5的复合结果。研究区的所有救护响应的结果,.04%有关医院外交付。分析了216分分为医院外交货。共有111个,其中111个发生在具有催产素的区域中,在该区域的救护车和105中没有。催产素在111个递送(51%)的57中施用,其中可用。初级结果没有差异(P?=氧杂蛋白可用的催产素548,P?=β=β.381用于未使用的催产素,在催产素可用的那些催产素的递送之间检测到二次结果Vs使用它的那些没有使用VS。结论本研究环境中的产后出血减少不相关。催产素似乎并不是所有救护车单位的必需药物。没有评估医院使用催产素,因此没有通过该研究的争议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号